Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Sight Sciences Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
SGHT
Nasdaq
3841
https://www.sightsciences.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Sight Sciences Inc
Sight Sciences to Report First Quarter Financial Results on May 2, 2024
- Apr 18th, 2024 8:05 pm
Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma
- Apr 10th, 2024 8:05 pm
Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting
- Apr 2nd, 2024 8:05 pm
Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference
- Mar 26th, 2024 8:05 pm
Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2023 Earnings Call Transcript
- Mar 8th, 2024 7:53 pm
Q4 2023 Sight Sciences Inc Earnings Call
- Mar 8th, 2024 2:16 pm
Sight Sciences Inc (SGHT) Navigates Challenges to Maintain Revenue Growth and Reduce Expenses
- Mar 8th, 2024 3:35 am
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates
- Mar 7th, 2024 10:50 pm
Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance
- Mar 7th, 2024 9:05 pm
Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024
- Feb 22nd, 2024 9:05 pm
Sight Sciences (SGHT) to Expand in Europe With New Launch
- Feb 21st, 2024 3:25 pm
Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting
- Feb 14th, 2024 9:05 pm
Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital
- Jan 23rd, 2024 9:05 pm
Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
- Jan 8th, 2024 9:05 pm
Sight Sciences Announces Withdrawal of Final LCDs on Micro-Invasive Glaucoma Surgery from Five Medicare Administrative Contractors
- Dec 28th, 2023 2:15 pm
Sight Sciences Announces the Publication of Successful Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease
- Dec 18th, 2023 9:05 pm
Sight Sciences Announces the Acceptance for Publication of GEMINI 2, a Three Year, Prospective, Multicenter Trial Demonstrating Sustained, Significant IOP and Medication Reductions Enabled with the OMNI® Surgical System Technology
- Dec 8th, 2023 1:05 pm
Independent Chairman of Sight Sciences Picks Up 14% More Stock
- Nov 24th, 2023 10:18 am
The Sight Sciences, Inc. (NASDAQ:SGHT) Analysts Have Been Trimming Their Sales Forecasts
- Nov 19th, 2023 12:13 pm
5 Risky Stocks to Buy Immediately, According to AI
- Nov 13th, 2023 8:40 pm
Scroll